-
Signature
-
/s/ Yukio Morikubo, Attorney in fact for Chris Diorio
-
Issuer symbol
-
PI
-
Transactions as of
-
15 Feb 2024
-
Transactions value $
-
-$833,518
-
Form type
-
4
-
Filing time
-
20 Feb 2024, 16:31:28 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PI |
Common Stock |
Options Exercise |
$109,050 |
+5,000 |
+1.97% |
$21.81 |
258,311 |
15 Feb 2024 |
Direct |
|
| transaction |
PI |
Common Stock |
Sale |
-$525,020 |
-5,000 |
-1.94% |
$105 |
253,311 |
15 Feb 2024 |
Direct |
F1 |
| transaction |
PI |
Common Stock |
Options Exercise |
$109,050 |
+5,000 |
+1.97% |
$21.81 |
258,311 |
16 Feb 2024 |
Direct |
|
| transaction |
PI |
Common Stock |
Sale |
-$526,598 |
-5,000 |
-1.94% |
$105.32 |
253,311 |
16 Feb 2024 |
Direct |
F2 |
| holding |
PI |
Common Stock |
|
|
|
|
|
572,494 |
15 Feb 2024 |
by DFT L.L.C. |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PI |
Stock Option (right to buy) |
Options Exercise |
$0 |
-5,000 |
-10.72% |
$0 |
41,661 |
15 Feb 2024 |
Common Stock |
5,000 |
$21.81 |
Direct |
F3 |
| transaction |
PI |
Stock Option (right to buy) |
Options Exercise |
$0 |
-5,000 |
-12% |
$0 |
36,661 |
16 Feb 2024 |
Common Stock |
5,000 |
$21.81 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: